ABRA INVEST advises HEMOSOLVE on its strategic development
22/03/2013
Diego Gutiérrez
ABRA INVEST advises HEMOSOLVE on its strategic development

ABRA INVEST has collaborated with HEMOSOLVE (exploitation of "sclerosing microfoam" for the treatment of haemorrhoids) through the design of a plan to develop its own clinics and agreements with other prestigious institutions.

History of microfoam sclerosants

In 1993 the Cabrera family invented the sclerosing microfoam. Since then it has been used to treat varicose veins effectively in more than 25,000 patients. As well as being treated in Cabrera's own 5 clinics, the treatment is used under licence by prestigious institutions such as the Clínica Universitaria de Navarra and Sanitas hospitals. Following the success of the microfoam treatment for varicose veins, the inventors have developed microfoam for haemorrhoids.

KEY POINTS:

1. Large size of affected population:

Symptomatic haemorrhoids affect at least 50% of the population at some point in their lives, with around 5% of the population suffering from them at any one time.
2. Advantages over surgery and others:
  • Outpatient treatment: no need for anaesthesia or surgery.
  • No specific post-treatment care and the patient can continue with normal life.
  • HEMOSOLVE can cure any type of haemorrhoid. Surgery only for the most acute ones.
  • Painless and easily repeatable procedure: The discomfort is similar to a blood draw.

3. Advantageous competitive position:

  • The technology is patented and IIDF has authorisation for use in Spain.
  • The treatment has been tested in more than 150 patients during 2011 and 2012 demonstrating its efficacy. The Granada Clinic is active.
  • Agreements with other institutions underway: agreement with Clínicas Cabrera to offer the treatment, agreement with Médico Digestivo to open a clinic in Madrid, etc.

The team composed of technical staff and professionals with business experience in the healthcare world is well prepared to develop the established business plan.

Diego Gutiérrez Zarza

Baker Tilly GDA

Lastest news

Últimas transacciones del sector Cybersecurity

El sector de la ciberseguridad ha sido testigo de una importante oleada de adquisiciones estratégicas en los últimos meses, a medida que las empresas tratan de ampliar sus capacidades y hacer frente a la creciente demanda de una sólida protección digital. Cinco...

Latest transactions in the Consumer Software sector

El sector del Consumer software ha experimentado recientemente una dinámica oleada de adquisiciones que pone de relieve su evolución hacia la mejora de la participación de los usuarios y la ampliación de los servicios digitales. Entre las operaciones más destacadas...

Latest transactions in the Industrial Tech sector

El sector de la tecnología industrial ha sido testigo de una oleada de transacciones estratégicas en los últimos meses, señal de una rápida evolución y expansión. Entre las operaciones más destacadas, Bosch Energy and Building Solutions adquirió DMS Ettlingen para...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42